Clinical Trial Update: Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating daily glycomacropeptide consumption and its effects on the gut microbiome and blood proteome in individuals with irritable…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Glycomacropeptide (glycomacropeptide)

Snippet

Sponsor: Oregon State University | Conditions: Inflammatory Bowel Syndrome | NA | Status: COMPLETED